Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Nides

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|March 26, 2008
Update on pharmacologic options for smoking cessation treatmentMitchell Nides
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 19, 2004
Smoking reduction in the Lung Health StudyJohn Hughes, Paula Lindgren, John Connett, et al.
Harm Reduction Journal|June 30, 2018
Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USAChristopher Russell, Neil McKeganey, Tiffany Dickson, et al.
Preventive Cardiology|March 31, 2007
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventionsMitchell Nides, Scott Leischow, Linda Sarna, et al.
BMC Clinical Pharmacology|October 10, 2007
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell)Bertrand Dautzenberg, Mitchell Nides, Jean-Luc Kienzler, et al.
American Journal of Health Behavior|April 18, 2018
Nicotine Lozenges in the Relief of Behaviorally Provoked CravingMitchell Nides, Gilbert Marava Shanga, Amanda Bishop, et al.
Psychopharmacology|May 1, 2014
Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokersDaniel Du, Mitchell Nides, James Borders, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 13, 2021
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)Mitchell Nides, Nancy A Rigotti, Neal Benowitz, et al.
Archives of Internal Medicine|August 16, 2006
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-upMitchell Nides, Cheryl Oncken, David Gonzales, et al.
Archives of Internal Medicine|August 16, 2006
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessationCheryl Oncken, David Gonzales, Mitchell Nides, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|March 26, 2008
Update on pharmacologic options for smoking cessation treatmentMitchell Nides
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 19, 2004
Smoking reduction in the Lung Health StudyJohn Hughes, Paula Lindgren, John Connett, et al.
Harm Reduction Journal|June 30, 2018
Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USAChristopher Russell, Neil McKeganey, Tiffany Dickson, et al.
Preventive Cardiology|March 31, 2007
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventionsMitchell Nides, Scott Leischow, Linda Sarna, et al.
BMC Clinical Pharmacology|October 10, 2007
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell)Bertrand Dautzenberg, Mitchell Nides, Jean-Luc Kienzler, et al.
American Journal of Health Behavior|April 18, 2018
Nicotine Lozenges in the Relief of Behaviorally Provoked CravingMitchell Nides, Gilbert Marava Shanga, Amanda Bishop, et al.
Psychopharmacology|May 1, 2014
Comparison of nicotine oral soluble film and nicotine lozenge on efficacy in relief of smoking cue-provoked acute craving after a single dose of treatment in low dependence smokersDaniel Du, Mitchell Nides, James Borders, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 13, 2021
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial)Mitchell Nides, Nancy A Rigotti, Neal Benowitz, et al.
Archives of Internal Medicine|August 16, 2006
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-upMitchell Nides, Cheryl Oncken, David Gonzales, et al.
Archives of Internal Medicine|August 16, 2006
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessationCheryl Oncken, David Gonzales, Mitchell Nides, et al.
Pageof 2